World Journal of Experimental Medicine - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 1111184

Number of visits today: 290

Number of downloads: 764056

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 4 (375)

Contents Volume 13 Issue 4 September 20, 2023

Review

Neurologic orphan diseases: Emerging innovations and role for genetic treatments

Brandon Lucke-Wold, Eduardo E Molina Valero, Rebecca M Toms, Brandon J Burgess, Marco A Foreman, Rajvi N Thakkar, Devon T Foster, Ivelina P Kioutchoukova

World J Exp Med 13(4):59-74. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.59

Abstract (1301) | Core Tip (1210) | Full Article (HTML) (4435) | Figures (1-5) (599) | Full Article (PDF)-2841K (309) | Full Article with Cover (PDF)-3034K (249) | Full Article (XML)-303K (151) | Audio-333K (14) | Peer-Review Report-234K (158) | Answering Reviewers-110K (171) | Received: 06/17/2023 | Revised: 07/16/2023 | Accepted: 08/11/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (6) | Total Visits (11799) | Similar Articles (0) | Timeline of Article Publication (4) | Authors Evaluation (2) | Article Quality Tracking (1) | What about the content of this article? (0) | Cite |

(0) | Open

Basic Study

Personalized clinical managements through exploring circulating neural cells and electroencephalography

Parvin Mehdipour, Nima Fathi, Masoud Nosratabadi

World J Exp Med 13(4):75-94. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75

Abstract (1056) | Core Tip (1224) | Article Highlights (1127) | Full Article (HTML) (2846) | Figures (1-13) (554) | Tables (1-2) (546) | Full Article (PDF)-18536K (258) | Full Article with Cover (PDF)-18729K (223) | Full Article (XML)-148K (151) | Audio-2276K (13) | Peer-Review Report-245K (149) | Answering Reviewers-304K (162) | Received: 01/20/2023 | Revised: 05/22/2023 | Accepted: 07/11/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (12518) | Similar Articles (3) | Timeline of Article Publication (3) | Authors Evaluation (1) | Article Quality Tracking (1) | What about the content of this article? (0) | Cite |

(0) | Open

Letter to the Editor

Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis

Marco Zeppieri

World J Exp Med 13(4):95-98. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.95

Abstract (1229) | Core Tip (1143) | Full Article (HTML) (2874) | Full Article (PDF)-359K (193) | Full Article with Cover (PDF)-553K (190) | Full Article (XML)-43K (174) | Audio-345K (10) | Peer-Review Report-218K (143) | Answering Reviewers-111K (152) | Received: 04/21/2023 | Revised: 05/16/2023 | Accepted: 06/16/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (10070) | Similar Articles (726) | Timeline of Article Publication (0) | Authors Evaluation (1) | Article Quality Tracking (2) | What about the content of this article? (0) | Cite |

(0) | Open

Update on hydroxychloroquine use in pregnancy

Wassan Nori, Nabeeha Najatee Akram, Raid M Al-Ani

World J Exp Med 13(4):99-101. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.99

Abstract (1397) | Core Tip (1414) | Full Article (HTML) (4507) | Full Article (PDF)-351K (260) | Full Article with Cover (PDF)-545K (222) | Full Article (XML)-43K (166) | Audio-1788K (11) | Peer-Review Report-230K (159) | Answering Reviewers-85K (140) | Received: 04/13/2023 | Revised: 07/05/2023 | Accepted: 07/24/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (4) | Total Visits (12049) | Similar Articles (147) | Timeline of Article Publication (0) | Authors Evaluation (5) | Article Quality Tracking (2) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345